Search for: "MedImmune, LLC"
Results 1 - 20 of 33
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
16 Aug, 2008 2:29 am by Lawrence B. Ebert
... 1941). Instead of a bright-line rule, "the analysis must be calibrated to the particular facts of each case," Cat Tech LLC, 528 F.3d at 879, with the basic standard being whether "the facts alleged, under all the circumstances, show that there ... , 445 U.S. 388, 397 (1980) (mootness)). **The CAFC grabs for a bit of "reasonable apprehension" --> Prior to MedImmune, this circuit had generally required that a declaratory judgment plaintiff in a patent dispute demonstrate (1) conduct by the patentee ...
IPBiz - http://ipbiz.blogspot.com
8 Aug, 2008 3:24 pm by nipper
PHOSITA blog with a copy of the order in what appears to be the First Post Medimmune DJ Dismissal. See also: Patent Baristas - Supreme Court High-Fives MedImmune, Wikipedia - MedImmune, Inc. v. Genentech, Inc. [Originally posted on The Invent Blog. Copyright © Nipper, LLC 2004-2007. All Rights Reserved.]
The Invent Blog - http://www.inventblog.com/patent/
29 May, 2008 3:09 pm
... activity, is still relevant to the jurisdictional analysis. As stated by the court (internal citations omitted): We conclude that although MedImmune articulated a "more lenient legal standard" for the availability of declaratory judgment relief in patent cases, the issue of whether there ... construction because it would render the limitation functionally meaningless, and described the plaintiff's position as "semantic antics." More detail on CAT Tech. LLC v. TubeMaster, Inc. after the jump. [More]
Filewrapper.com - http://www.Filewrapper.com/index.cfm
29 May, 2008 6:01 am
Cat Tech LLC v. TubeMaster, Inc. (2007-1443), May 28, 2008 TubeMaster developed a method of putting catalyst into reactor tubes using loading devices. Tube Master designed four different configurations for ... prong, namely, that TubeMaster's "other configurations" were not developed enough to quality as potentially infringing activity. While MedImmune did not directly address the second prong, the CAFC concluded that "the issue of whether there has been meaningful preparation to conduct potentially ...
Two-Seventy-One Patent Blog - http://271patent.blogspot.com
19 Aug, 2008 4:54 am by Donald Zuhn
... plenary powers under Article III of the Constitution. Among these decisions (including KSR Int'l Co. v. Teleflex Inc., eBay Inc. v. MercExchange, LLC, Quanta Computer, Inc. v. LG Electronics, Inc., Merck KGAA v. Integra Lifesciences I, Ltd., Microsoft Corp. v. AT&T Corp., Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., Dickinson v. Zurko), perhaps the one that provoked the most extreme reaction from the Federal Circuit was Medimmune, Inc....
Patent Docs - http://patentdocs.typepad.com/patent_docs/
3 Aug 8:59 pm by Patent Docs
... -- Settlement Announced in Ethyol® Infringement Suit Sun Pharmaceutical Industries, Ltd. and Medimmune LLC have announced a settlement of their patent dispute regarding Sun's manufacture ... Sun and its U.S. affiliate, Caraco Pharmaceutical Laboratories Ltd., had infringed Medimmune's patents covering Ethyol®, U.S. Patent Nos. 5,424,471 ... 5,591,731. The U.S. District Court for the District of Maryland, having noted that Medimmune stated that Sun and Caraco had not infringed any of the process claims of ...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
1 Mar 9:07 pm by Patent Docs
By Sherri Oslick --About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.MedImmune, LLC v. Sun Pharmaceutical Industries Ltd. et al.1:09-cv-00452; filed ... Amifostine Compositions," issued January 7, 1997) based on defendants' manufacture and sale of a generic version of MedImmune's Ethyol® (amifostine, used to treat xerostomia in patients receiving radiation...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
15 Sep 2:30 pm by Lucas A. Ferrara, Esq.
... news for our nation's response to the 2009 H1N1 influenza virus," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "This vaccine will help protect individuals from serious illness and death from influenza." The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. All four firms manufacture the H1N1 vaccines using the same processes, which have a ...
Real Estate Law Blog - http://www.nyrealestatelawblog.com/
5 Oct 7:48 pm
... can they make a decision on the safety before all the data is in? I ask that question, but is there any doubt what the results of the studies will recommend? On August 15, 2009, the FDA approved vaccines made by the following companies: CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited and Sanofi Pasteur. All four firms manufacture the H1N1 vaccines using the same processes. It is important to ...
CAMLAW : Complementary And Alternative Medicine Law Blog - http://www.camlawblog.com/
5 Oct 7:48 pm
... can they make a decision on the safety before all the data is in? I ask that question, but is there any doubt what the results of the studies will recommend? On August 15, 2009, the FDA approved vaccines made by the following companies: CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited and Sanofi Pasteur. All four firms manufacture the H1N1 vaccines using the same processes. It is important to ...
CAMLAW : Complementary And Alternative Medicine Law Blog - http://www.camlawblog.com/
21 Oct 7:57 am by Barbara Tubridy Lombardi
... to the Mayo Clinic this allergy does not necessarily preclude you from receiving the vaccine. There are tests available that will establish if you are able to tolerate the H1N1 vaccine. The FDA has posted the insert for the intranasal H1N1 vaccine manufactured by MedImmune LLC. The Novartis manufactured H1N1 vaccine product information can be found at this FDA website. Glaxo Smith Kline, another manufacturer of the vaccine did ...
Des Moines Personal Injury Lawyer - http://desmoines.injuryboard.com/
14 Jan, 2008 10:22 am by Sheppard Mullin
... judgment suit for invalidity. The Court found that a case or controversy existed even though Medimmune continued to pay royalties and could not be sued for infringement. Thus, certain ... generally more likely that a declaratory judgment suit can be brought and maintained. Medimmune, Inc. v. Genentech, Inc., 127 U.S. 764 (2007). The Federal ... high likelihood that its actions constituted infringement of a valid patent." In re Seagate Tech., LLC, 497 F.3d 1360 (Fed. Cir. 2007). 2. The Federal Circuit ...
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
3 Sep, 2008 10:46 pm
By Audrey Millemann In Prasco, LLC v. Medicis Pharmaceutical Corp., 2008 WL 3546217 (Fed. Cir. 2008), the Federal Circuit Court of Appeals has further limited the test for subject matter jurisdiction in declaratory ... objective standard that cannot be met by a purely subjective or speculative fear of future harm. Thus as we explained post-MedImmune, 'jurisdiction generally will not arise merely on the basis that a party learns of the existence of a patent owned by another or even perceives such a ...
IP Law Blog - http://www.theiplawblog.com/
29 May, 2008 1:22 pm by Dennis Crouch
Cat Tech LLC v. TubeMaster, Inc. (Fed. Cir. 2008) Cat sued TubeMaster - alleging infringement of its patent covering a method of using a catalyst loading devices to simultaneously load thousands of tube ... apprehension that the patentee will file suit and (2) conduct "meaningful preparation" to conduct potentially infringing activity. The MedImmune decision eliminated the first prong - finding the that the "reasonable apprehension" test excluded at least some actual "cases and controversies" under ...
Patently-O - http://www.patentlyo.com/patent/
30 May, 2008 9:09 am
... plaintiff must take 'significant, concrete steps to conduct infringing activity' to satisfy MedImmune test: Cat Technologies v Tubemaster: (Peter Zura's 271 Patent ... suggestion grounds: Ranbaxy Australia Pty Ltd v Warner-Lambert Company LLC: (GenericsWeb), (IPRoo), (IP Law360), Lipitor (Atorvastatin) - Canada: Court of Appeal upholds ... amp; Co: (IMPACT), (Rouse & Co International), Synagis (Palivizumab) - US: MedImmune, Genentech strike deal in Synagis patent case: (IP Law360), (Patent Baristas ...
IP Thinktank - http://duncanbucknell.com/blog
21 Aug, 2008 9:43 pm
... was seeking a declaration of noninfringement. The district court granted a motion to dismiss the under the Federal Circuit's pre-MedImmune reasonable apprehension of suit test, noting that there was no reasonable apprehension of suit. In a footnote, the court noted that ... or speculative fear of future harm." As a result, considering the totality of the circumstances, the court affirmed the district court's dismissal of the case. More on Prasco LLC v. Medicis Pharm. Corp. after the jump. [More]
Filewrapper.com - http://www.Filewrapper.com/index.cfm
1 Nov, 2008 3:12 am
... : collateral review of PTO process (IP Frontline) Declaratory judgment jurisprudence after Medimmune (IP Frontline) (Patent Docs) Design patents 'point of novelty' test jettisoned: ... ) CAFC publishes frivolous appeal sanction: Systems Division, Inc v Teknek, LLC (Hal Wegner) CAFC upholds trial court's rejection of Marvell Semiconductor's ... 2(d) refusals of RSI design mark for ink jet printers: In re RSI Systems, LLC (The TTABlog) NO BROKEN GLASS symbol fails to function as a trade mark for lighting ...
IP Thinktank - http://duncanbucknell.com/blog
7 Jan 2:40 pm by Lawrence B. Ebert
... jurisdictional questions in declaratory judgment actions, there is no bright-line rule. MedImmune, 127 S. Ct. at 771. Instead, "the question in each case is whether the facts ... case. However, the district court expressly acknowledged the correct legal test under MedImmune and plainly took all the relevant facts into account in determining subject ... standard that cannot be met by a purely subjective or speculative fear of future harm." Prasco, LLC v. Medicis Pharm. Corp., 537 F.3d 1329, 1338 (Fed. ...
IPBiz - http://ipbiz.blogspot.com
28 May, 2008 6:35 am by Bill Heinze
In Cat Tech. LLC. v. Tubemaster Inc. May 28, 2008), the U.S. Court of appeals for the Federal Circuit examined the second prong of the thw-prong test for determining the existence of declaratory judgment authority ... must be considered in determining whether a declaratory judgment is appropriate. See Teva Pharms., 482 F.3d at 1339 (MedImmune requires that a court look at "all the circumstances" to determine whether a justiciable Article III controversy exists.). If a declaratory judgment plaintiff ...
I/P Updates - http://ip-updates.blogspot.com
28 May, 2008 7:05 pm
Case: Cat Tech. LLC. v. Tubemaster Inc., Fed. Cir. No. 07-1443 (5/28/08) The One Sentence Summary: The second prong of the Federal ... Circuit's declaratory judgment test survives after the Supreme Court's Medimmune decision, and was met here where the accused infringer had made preparations to infringe ... spacing requirements set out in claim language. Federal Circuit Holdings: "[A]lthough MedImmune articulated a "more lenient legal standard" for the availability of declaratory judgment relief in patent ...
IP Law Observer - http://www.iplawobserver.com
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck